News

Verastem: The Market Is Ignoring The Progress
Verastem's FDA approval for KRAS-mutant LGSOC, strong pipeline, and catalysts signal growth potential. Click here to read an ...
Ensysce Biosciences Initiates Pivotal Phase 3 Study of PF614 - A Next-Generation Opioid - Designed to Deliver Powerful Pain Relief and Reduce Abuse
FDA Protocol Review Completed ~~ Rho, Inc. Selected as Clinical Research Partner ~ SAN DIEGO, CA / ACCESS Newswire / July 16, 2025 / Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company" ...
Pharmabiz2h
Merck to initiate EXPrESSIVE phase 3 trials of MK-8527, an investigational once-monthly HIV prevention pill
Rahway, New Jersey Wednesday, July 16, 2025, 17:30 Hrs [IST] ...
WHO Extended Global Emergency Status of MPox Epidemic - Development of Treatment for MPox with NV-387 is Timely, Says NanoViricides
NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global ...
ICON plc: ICON's Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report
ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research organisations (CRO) for phase 1 clini ...
News-Medical.Net11h
UNM researchers get $1 million grant to launch early clinical trial for Alzheimer’s vaccine
University of New Mexico researchers have received funding to launch an early-stage clinical trial of a vaccine engineered to ...